All news
  • Labeling - a step forward or stagnation?

    There is a threat of a lack of drugs in Russia, said experts of the round table "Labeling of Medicines" on the air of the radio "Komsomolskaya Pravda". Since July 1, the mandatory labeling of drugs has started, but manufacturers will soon be able to obtain permission from the interdepartmental commission and produce drugs without labeling until October 1. While some companies are waiting for permission, others are faced with technical failures and many hours of downtime when using the system under load. The lack of a clear understanding of the situation and jointly developed actions and solutions in a particular situation between government agencies and the pharmaceutical industry does not give positive results.

  • It is necessary to raise the degree of confidence in labeling

    On July 1, compulsory labeling of medicines began. On the same day, the industry learned about Government Decision No. 955, signed on the eve, “On the Peculiarities of Putting Medicines into the Civil Circuit for Medical Use”. Despite the numerous appeals of industry associations to the authorities, their fears about problems with the launch of the system and a possible lack of drugs  are still left without proper attention and the Resolution did not remove all the issues of the industry.

  • Labeling started. What is next?

    From July 1, 2020, labeling of drugs becomes mandatory in Russia. However, no one gives guarantees of its uninterrupted operation, especially since the industry announced that it was not ready to start. The State Duma has prepared amendments to Federal Law No. 61 “On the Circulation of Medicines,” which should give the government the right to postpone the introduction of mandatory labeling of medicines in full. In the near future, they will be discussed in the third reading.

  • From July 1, marking starts in manual mode

    Around the introduction of mandatory labeling of drugs in Russia there has been controversy for several years. Today the situation has escalated. There will be no postponing of start labeling. The inter-factional working group on improving the legislation in the field of drug provision recommended the Government a safe entry into the system from July 1. The Ministry of Health assured the deputies that there would be no problems with drug provision.

  • The pharmaceutical industry asked Vladimir Putin to postpone labeling start for 2021

    11 pharmaceutical industry organizations uniting drug manufacturers, distributors, pharmacy organizations, the patient community wrote a collective letter addressed to President of the Russian Federation Vladimir Putin, in which draw attention of the head of state to the unpreparedness to launch industrial operation of the drug movement monitoring (DMM) system and give arguments why it is necessary to postpone the start scheduled for July 1, 2020.

  • Fifty days before the start or how to live after July 1?

    Labeling of drugs starts on July 1, or again, for objective reasons, the start will be postponed? The issue of postponing the start of drug labeling is particularly acute in a pandemic when the uninterrupted and timely provision of drugs to patients is crucial. The pharmaceutical industry, while supporting and understanding the importance of introducing a labeling system, also notes the risks associated with the launch of a system that is not 100% ready. The world situation associated with the threat of the spread of coronavirus has led to quarantine restrictions, which negatively affects the ability to start the system on time.

  • Let's try to solve something that is easy to solve

    In the created difficult conditions, it is impermissible luxury not to use and doom quality and safe medicines to spoilage. The law enforcement practice of suspension of circulation of drugs due to the identification of comments on production is such that the drug waits for the resumption of circulation in the warehouse until the identified comments are eliminated. Correction of comments is confirmed by repeated (control) inspection of production. Today, on-site inspection has become impossible due to quarantine restrictions. Accordingly, drugs deprived of circulation are waiting for the expiration date getting "dusty" in warehouses. Is it right and prudent? Of course not, especially since patients who interrupted therapy suffer from this.


All projects

Membership of ARFP in the Organizations

Russian Union of Industrialists
and Entrepreneurs (RSPP)

Chamber of Commerce and Industry (CCI)
of the Russian Federation

Awards of Association

Partners of association